Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AXIL Brands Reports Second Quarter Fiscal Year 2025 Financial Results
-
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials
-
Sky Quarry Receives Permission to Operate Fractionation Facility at Eagle Springs Refinery Site, Advancing Waste-to-Energy Vision
-
PodcastOne (NASDAQ: PODC) Named 8th Largest US Podcast Publisher by Podtrac for December 2024; Renews Flagship Podcasts with Adam Carolla, Brendan Schaub and Kaitlyn Bristowe
-
UMeWorld Transforms into a Full-Spectrum Wellness Brand with AI-Powered Personalized Solutions
-
Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
Acres Debuts Layer Library: Combine and Visualize Land Data Seamlessly
-
authID Receives Industry Luminary Classification in The Prism Project’s 2024 Biometric Digital Identity Flagship Report
-
Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
-
Magna International Inc. Announces Date for Q4 & Year End 2024 Results and 2025 Outlook Webcast
-
Bitcoin Depot Expands BTM Network Through Partnership with Prominent Texas Convenience Store Chain
-
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
-
Kratos Awarded $48 Million Contract for Geolocation Global Support Services
-
STACK Infrastructure Advances Data Center Safety and Releases Breaker Guard Design into Public Domain
-
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies
-
Acronis Appoints Gerald Beuchelt as Chief Information Security Officer
-
DiagnaMed and QIMC to Advance Hydrogen Production Technology at the Ville Marie Clean Natural Renewable Hydrogen Project
-
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections
-
Advanced Ionics Raises $6.7M to Accelerate Technology Commercialization and Deployment
-
Blimburn Seeds Announces USA Expansion
-
Collegium Provides 2025 Financial Guidance and Business Update
-
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Live Oak Bancshares, Inc. Announces Date of Fourth Quarter 2024 Financial Results
-
New TransUnion Research Reveals Seven in 10 Marketing Leaders Struggle to Connect with Audiences Due to Complex Network of Martech Solutions and Identity Challenges
-
Bonaccord Capital Partners Announces Fund II Final Close at $1.6 Billion
-
Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Horizon Aircraft Announces Exercise of Warrants, Providing an Additional $2.7 Million in Gross Proceeds
-
Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
-
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Notice of annual general meeting of Gabriel Holding A/S
-
Copenhagen Infrastructure Partners charges to the top of the UK battery stack
-
Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQ™ technology
-
BitMEX Launches Multi Asset Margining: Simplifying Trading for Derivatives Markets
-
Form 8.3 - Warpaint London Plc
-
Form 8.3 - Renewi Plc
-
Form 8.3 - Learning Technologies Group Plc
-
Alliance Witan PLC - Net Asset Value
-
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
-
Foresight Regains Compliance with Nasdaq Minimum Bid Price Rule
-
Amplify ETFs to Liquidate the Amplify U.S. Alternative Harvest ETF (MJUS)
-
Nayax, the Leader in Seamless Payment and Commerce Solutions, Set to Unveil 'Retail Your Way' at NRF 2025
-
Angitia Biopharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
-
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
-
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
-
Gaxos to Participate in The Sequire Investor Summit on January 21st – 23rd in San Juan, Puerto Rico
-
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
-
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
-
Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare Conference
